Back
Scholar Rock Holding Vs. X4 Pharmaceuticals Industry Stock Comparison
Sell
40
SRRK
Scholar Rock Holding
Last Price:
8.75
Seasonality Move:
64.81%
Sell
45
XFOR
X4 Pharmaceuticals
Last Price:
0.65
Seasonality Move:
-7.5%
Sell
40
Scholar Rock Holding (SRRK)
is a Sell
Is Scholar Rock Holding a Buy, Sell or Hold?
- The current Scholar Rock Holding [SRRK] share price is $8.73. The Score for SRRK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SRRK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
X4 Pharmaceuticals (XFOR)
is a Sell
Is X4 Pharmaceuticals a Buy, Sell or Hold?
- The current X4 Pharmaceuticals [XFOR] share price is $0.66. The Score for XFOR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- XFOR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRRK Stock Price Chart
What is Scholar Rock Holding's stock price today?
-
The Scholar Rock Holding share price today is $8.73
The current trend is relatively stagnant and SRRK is experiencing slight buying pressure.
XFOR Stock Price Chart
What is X4 Pharmaceuticals's stock price today?
-
The X4 Pharmaceuticals share price today is $0.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFOR is experiencing slight selling pressure.
SRRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.07 | Sell |
Relative Strength Index (14 RSI): | 49.95 | Sell |
Chaikin Money Flow: | 77659 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.35 - 9.15) | Sell |
Bollinger Bands (100): | (7.82 - 11.1) | Sell |
XFOR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.2 | Sell |
Chaikin Money Flow: | -480162 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.66 - 0.72) | Sell |
Bollinger Bands (100): | (0.64 - 0.96) | Sell |
SRRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.69 | Buy |
20-day SMA: | 8.63 | Buy |
50-day SMA: | 8.89 | Sell |
200-day SMA: | 12.64 | Sell |
8-day EMA: | 8.67 | Buy |
20-day EMA: | 8.7 | Buy |
50-day EMA: | 8.96 | Sell |
200-day EMA: | 10.69 | Sell |
XFOR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.69 | Sell |
20-day SMA: | 0.68 | Sell |
50-day SMA: | 0.71 | Sell |
200-day SMA: | 0.89 | Sell |
8-day EMA: | 0.68 | Sell |
20-day EMA: | 0.68 | Sell |
50-day EMA: | 0.72 | Sell |
200-day EMA: | 0.89 | Sell |
Scholar Rock Holding Earnings Growth & SRRK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.39 per share, and an increase next year of $0.26 per share.
X4 Pharmaceuticals Earnings Growth & XFOR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.04 per share, an increase this year of $0.50 per share, and a decrease next year of $0.35 per share.
Scholar Rock Holding Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
X4 Pharmaceuticals Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |